Use of immunoglobulins in the prevention of GvHD in a xenogeneic NOD/SCID/γc- mouse model.
about
OKT3 prevents xenogeneic GVHD and allows reliable xenograft initiation from unfractionated human hematopoietic tissues.Targeting the Human T-Cell Inducible COStimulator Molecule with a Monoclonal Antibody Prevents Graft-vs-Host Disease and Preserves Graft vs Leukemia in a Xenograft Murine ModelAnti-inflammatory IgG production requires functional P1 promoter in β-galactoside α2,6-sialyltransferase 1 (ST6Gal-1) geneXenogeneic graft-versus-host-disease in NOD-scid IL-2Rγnull mice display a T-effector memory phenotype.Preemptive administration of human αβ T cell receptor-targeting monoclonal antibody GZ-αβTCR potently abrogates aggressive graft-versus-host disease in vivo.Humanized Chronic Graft-versus-Host Disease in NOD-SCID il2rγ-/- (NSG) Mice with G-CSF-Mobilized Peripheral Blood Mononuclear Cells following Cyclophosphamide and Total Body Irradiation.Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic TumorsIn vivo expansion of co-transplanted T cells impacts on tumor re-initiating activity of human acute myeloid leukemia in NSG miceIL-21 accelerates xenogeneic graft-versus-host disease correlated with increased B-cell proliferation.Attenuation of graft-versus-host-disease in NOD scid IL-2Rγ(-/-) (NSG) mice by ex vivo modulation of human CD4(+) T cells.Clinical impact of hematogones on outcomes of allogeneic hematopoietic stem cell transplantation.Trogocytosis in allogeneic transplants: donor cells take on the recipients identity.Human T cells depend on functional calcineurin, tumour necrosis factor-α and CD80/CD86 for expansion and activation in mice.Analysis of human biologics with a mouse skin transplant model in humanized mice.Blocking immune intrusion into the brain suppresses epilepsy in Rasmussen's encephalitis model.Humanized mouse model of Rasmussen's encephalitis supports the immune-mediated hypothesis.Modeling Human Graft-Versus-Host Disease in Immunocompromised Mice.Risk factors for hypogammaglobulinemia after allo-SCT
P2860
Q33749684-F61F045B-F816-4FE5-869D-20022EF0381EQ33854453-B02400D3-5FB3-47B9-8EFE-44A306AD9702Q34199547-37DB508A-40BA-4D85-823A-6D924622EBB4Q34399707-3950D3B7-932D-468F-936E-571E622F5280Q34489151-CB94E6A6-24BF-4212-9C1B-DD15888CA3A7Q35692054-BDDB8220-6E92-4AFC-8653-F52A9B1182C2Q36177642-8F002286-F555-436E-B550-4FAEF63A1212Q36753942-69847C19-F298-4407-8F9E-DDCD990B6D6CQ36923019-A8483ADC-19C8-4CF1-B328-CE8907315BF6Q38827908-F6BB85B9-5505-4882-B631-A922EA92F4AAQ41017468-C32F60CB-982C-4DEC-A992-FA9F60BB6F6BQ41947441-1843BDC2-1593-415F-B2B4-68ED660933A1Q43514712-AF8F793D-5506-4ABB-9323-6992128AAC86Q50942355-74D8538E-C701-4B5F-8BD3-2C31C2E07C0EQ52599095-B1659350-0E07-44BA-9EA8-E71C55C42B99Q52720739-4E4D2360-660E-4CFB-AE23-29EE6D3ED5CEQ54301994-BD0FBB36-3AF2-4151-A091-0EDB6F3085C6Q58470540-68DF2E01-40AD-45F3-8641-4B410145B585
P2860
Use of immunoglobulins in the prevention of GvHD in a xenogeneic NOD/SCID/γc- mouse model.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Use of immunoglobulins in the ...... neic NOD/SCID/γc- mouse model.
@en
Use of immunoglobulins in the ...... neic NOD/SCID/γc- mouse model.
@nl
type
label
Use of immunoglobulins in the ...... neic NOD/SCID/γc- mouse model.
@en
Use of immunoglobulins in the ...... neic NOD/SCID/γc- mouse model.
@nl
prefLabel
Use of immunoglobulins in the ...... neic NOD/SCID/γc- mouse model.
@en
Use of immunoglobulins in the ...... neic NOD/SCID/γc- mouse model.
@nl
P2093
P2860
P356
P1476
Use of immunoglobulins in the ...... neic NOD/SCID/γc- mouse model.
@en
P2093
F Fontaine
J Gregoire-Gauthier
N Patey-Mariaud de Serre
P2860
P2888
P304
P356
10.1038/BMT.2011.93
P407
P577
2011-05-16T00:00:00Z
P5875
P6179
1011498187